Nagata S
Proc Jpn Acad Ser B Phys Biol Sci. 2023; 100(1):1-14.
PMID: 37648466
PMC: 10864172.
DOI: 10.2183/pjab.100.001.
Raphael V, Shanmughan S
Adv Pharmacol Pharm Sci. 2020; 2020:8818008.
PMID: 33015628
PMC: 7520694.
DOI: 10.1155/2020/8818008.
Weiss R
Cancer Metastasis Rev. 2020; 39(4):1023-1028.
PMID: 32728828
PMC: 7680315.
DOI: 10.1007/s10555-020-09919-1.
Zavyalov V, Hamalainen-Laanaya H, Korpela T, Wahlroos T
Clin Chem. 2018; 65(6):739-750.
PMID: 30593466
PMC: 7108468.
DOI: 10.1373/clinchem.2018.292391.
Bazhin A, von Ahn K, Fritz J, Werner J, Karakhanova S
Front Immunol. 2018; 9:2129.
PMID: 30356906
PMC: 6190899.
DOI: 10.3389/fimmu.2018.02129.
Diagnosis and Medical Management of Ocular Surface Squamous Neoplasia.
Sayed-Ahmed I, Palioura S, Galor A, Karp C
Expert Rev Ophthalmol. 2017; 12(1):11-19.
PMID: 28184236
PMC: 5293314.
DOI: 10.1080/17469899.2017.1263567.
Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon.
Friedman R, Contente S
Pharmaceuticals (Basel). 2016; 2(3):206-216.
PMID: 27713234
PMC: 3978543.
DOI: 10.3390/ph2030206.
IFNA2: The prototypic human alpha interferon.
Paul F, Pellegrini S, Uze G
Gene. 2015; 567(2):132-7.
PMID: 25982860
PMC: 5629289.
DOI: 10.1016/j.gene.2015.04.087.
Twenty-five years of type I interferon-based treatment: a critical analysis of its therapeutic use.
Antonelli G, Scagnolari C, Moschella F, Proietti E
Cytokine Growth Factor Rev. 2015; 26(2):121-31.
PMID: 25578520
PMC: 7108252.
DOI: 10.1016/j.cytogfr.2014.12.006.
Maltose-binding protein fusion allows for high level bacterial expression and purification of bioactive mammalian cytokine derivatives.
Pennati A, Deng J, Galipeau J
PLoS One. 2014; 9(9):e106724.
PMID: 25198691
PMC: 4157803.
DOI: 10.1371/journal.pone.0106724.
Concepts of tissue injury and cell death in inflammation: a historical perspective.
Wallach D, Kang T, Kovalenko A
Nat Rev Immunol. 2013; 14(1):51-9.
PMID: 24336099
DOI: 10.1038/nri3561.
25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end.
Heim M
Nat Rev Immunol. 2013; 13(7):535-42.
PMID: 23743475
DOI: 10.1038/nri3463.
Interferons as inducers of apoptosis in malignant cells.
Kotredes K, Gamero A
J Interferon Cytokine Res. 2013; 33(4):162-70.
PMID: 23570382
PMC: 3624694.
DOI: 10.1089/jir.2012.0110.
IFN-α subtypes: distinct biological activities in anti-viral therapy.
Gibbert K, Schlaak J, Yang D, Dittmer U
Br J Pharmacol. 2012; 168(5):1048-58.
PMID: 23072338
PMC: 3594665.
DOI: 10.1111/bph.12010.
The end of the road.
Weissmann C
Prion. 2012; 6(2):97-104.
PMID: 22437734
PMC: 3366357.
DOI: 10.4161/pri.19778.
Optimization of cell culture conditions for production of biologically active proteins.
Hosoi S, Miyaji H, Satoh M, Kurimoto T, Mihara A, Fujiyoshi N
Cytotechnology. 2012; 5(Suppl 2):17-34.
PMID: 22359044
DOI: 10.1007/BF00573878.
Ipilimumab and cancer immunotherapy: a new hope for advanced stage melanoma.
Mansh M
Yale J Biol Med. 2011; 84(4):381-9.
PMID: 22180676
PMC: 3238313.
Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders.
Kelley K, Dantzer R
Brain Behav Immun. 2011; 25 Suppl 1:S13-20.
PMID: 21193024
PMC: 4068736.
DOI: 10.1016/j.bbi.2010.12.013.
Physiological responses to folate overproduction in Lactobacillus plantarum WCFS1.
Wegkamp A, Mars A, Faijes M, Molenaar D, de Vos R, Klaus S
Microb Cell Fact. 2010; 9:100.
PMID: 21167023
PMC: 3014895.
DOI: 10.1186/1475-2859-9-100.
Treatment of hepatitis C infections with interferon: a historical perspective.
Friedman R, Contente S
Hepat Res Treat. 2010; 2010:323926.
PMID: 21152181
PMC: 2989738.
DOI: 10.1155/2010/323926.